VVOS Stock Analysis: Buy, Sell, or Hold?
VVOS - Vivos Therapeutics, Inc. Common Stock
$0.43
-0.03 (-7.22%)
▼
5d:
-4.68%
30d:
-38.3%
90d:
-62.76%
BUY
HIGH Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 18, 2026
Get Alerted When VVOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called VVOS this week
60% bullish • 2 bearish
60% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: VVOS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: VVOS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: VVOS is currently trading at $0.43, which is considered slightly low relative to its 30-day fair value range of $0.42 to $0.66.
Technical Outlook: Technically, VVOS is in a strong downtrend. The price is currently testing key support at $0.62. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.12 (+390.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VVOS is in a strong downtrend. The price is currently testing key support at $0.62. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.12 (+390.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.42 -
$0.66
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.2%)
- BULLISH: Trading 390.0% below Wall St target ($2.12)
Trading Range Analysis
30-Day Trading Range
$0.42 -
$0.66
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.62
Resistance Level
$1.36
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.55
Wall Street Target
$2.12
(+390.0%)
Revenue Growth (YoY)
70.5%
Profit Margin
-127.7%
Share & Embed Analysis
Last updated: July 13, 2026 4:17 AM ET
Data refreshes hourly during market hours. Next update: 5:17 AM
Data refreshes hourly during market hours. Next update: 5:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VVOS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael C Skaff
BUY
1353625 shares
2026-03-31
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 58 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$98 | 64 BUY |
